Search
Twitter-square Facebook-square Linkedin Youtube

Appendix 3B New issue announcement of 6th June, 2018

Appendix 3B New issue announcement of 6th June, 2018

“Appendix 3B, New issue announcement, application for quotation of additional securities and agreement” of 6th June, 2018, is posted.
View and download Appendix 3B, New issue announcement, application for quotation of additional securities and agreement of 6th June, 2018.

Related Articles

Imagion AGM Business Update

May 29, 2025

MELBOURNE – Imagion Biosystems (Company, ASX: IBX), a company dedicated to improving healthcare outcomes through the early detection of cancer, is pleased to provide shareholders

Read More

Transforming medical imaging for early disease detection

We’re on a mission to make cancer more detectable.

Get in touch

About Imagion Biosystems

Imagion Biosystems (IBX) is an innovative medical imaging company that uses bio-safe magnetic nanoparticles to detect cancer and other diseases.

Contact us

  • info@imagionbio.com
  • Imagion Biosystems, Ltd. Suite 2, Level 11, 385 Bourke Street, Melbourne VIC 3000, Australia
  • AU +61 3 9692 7222
  • Imagion Biosystems, Inc. PO Box 4410 Incline Village, NV 89450 United States

Join our email list

Stay informed about our latest news and developments.

© Imagion Biosystems, Ltd. All Rights Reserved | Privacy Policy | Terms & Conditions | Careers | Corporate Governance

Twitter-square Facebook-square Linkedin Youtube